Sandoz and Evotec’s subsidiary, Just - Evotec Biologics have reached a multi-year, long-term tech alliance to develop and manufacture multiple biosimilars.
EQS-News: Evotec SE / Key word: Miscellaneous
Just – Evotec Biologics launches tech partnership for biosimilars development and commercial manufacturing
09.05.2023 / 20:07. | May 9, 2023
EQS-Ad-hoc: Evotec SE / Key word: Miscellaneous
Just – Evotec Biologics enters strategic biosimilars partnership with Sandoz
09-May-2023 / 20:05 CET/CEST
Disclosure of an inside. | May 9, 2023
EQS-News: Evotec SE / Key word(s): MiscellaneousEvotec presents paradigm shift in biologics at Capital Markets Day 02.11.2022 / 07:30 CET/CESTThe issuer is solely responsible for the content of this announcement. TOGETHER FOR MEDICINES THAT MATTER: A PARADIGM SHIFT TO UNLOCK NEW MARKETS AND OPPORTUNITIES FOR G.